XML 75 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Note 18 - Equity Incentive Plan
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

(18)

Equity Incentive Plan

 

In April 1999, the stockholders of the Company approved the Wilson Bank Holding Company 1999 Stock Option Plan (the “1999 Stock Option Plan”). The Stock Option Plan provided for the granting of stock options, and authorized the issuance of common stock upon the exercise of such options, for up to 200,000 shares of common stock, to officers and other key employees of the Company and its subsidiary. Furthermore, the Company and its subsidiary could reserve additional shares for issuance under the 1999 Stock Option Plan as needed in order that the aggregate number of shares that could be issued during the term of the 1999 Stock Option Plan was equal to five percent (5%) of the shares of common stock then issued and outstanding. The 1999 Stock Option Plan terminated on April 13, 2009, and no additional rewards may be issued under the 1999 Stock Option Plan. The awards granted under the 1999 Stock Option Plan prior to the plan's termination remained outstanding until exercised or otherwise terminated. As of December 31, 2019, the Company had outstanding no outstanding options under the 1999 Stock Option Plan.

 

In April 2009, the Company’s shareholders approved the Wilson Bank Holding Company 2009 Stock Option Plan (the “2009 Stock Option Plan”). The 2009 Stock Option Plan was effective as of April 14, 2009. Under the 2009 Stock Option Plan, awards could be in the form of options to acquire common stock of the Company. Subject to adjustment as provided by the terms of the 2009 Stock Option Plan, the maximum number of shares of common stock with respect to which awards could be granted under the 2009 Stock Option Plan was 100,000 shares. The 2009 Stock Option Plan terminated on April 13, 2019, and no additional awards may be issued under the 2009 Stock Option Plan. The awards granted under the 2009 Stock Option Plan prior to the Plan's expiration will remain outstanding until exercised or otherwise terminated. As of December 31, 2019, the Company had outstanding 20,065 options under the 2009 Stock Option Plan with a weighted average exercise price of $32.66.

 

As of December 31, 2019, the company had outstanding 140,908 stock options with a weighted average exercise price of $40.46 and $32.31. Cash settled stock appreciation rights with weighted average exercise price of $41.75.

 

In October 2019, the federal banking agencies approved final rules under the Growth Act that exempt a qualifying community bank and its holding company that have community bank leverage ratios, calculated as Tier 1 capital over average total consolidated assets, of greater than 9 percent from the risk-based capital requirements of the capital rules issued under the Dodd-Frank Act. A qualifying community banking organization and its holding company that have chosen the proposed framework are not required to calculate the existing risk-based and leverage capital requirements. Such a bank would also be considered to have met the capital ratio requirements to be well capitalized for the agencies' prompt corrective action rules provided it has a community bank leverage ratio greater than 9 percent.

 

During the second quarter of 2016, the Company’s shareholders approved the Wilson Bank Holding Company 2016 Equity Incentive Plan, which authorizes awards of up to 750,000 shares of common stock. The 2016 Equity Incentive Plan was approved by the Board of Directors and effective as of January 25, 2016 and approved by the Company’s shareholders on April 12, 2016. On September 26, 2016, the Board of Directors approved an amendment and restatement of the 2016 Equity Incentive Plan (as amended and restated the “2016 Equity Incentive Plan”) to make clear that directors who are not also employees of the Company may be awarded stock appreciation rights. The primary purpose of the 2016 Equity Incentive Plan is to promote the interest of the Company and its shareholders by, among other things, (i) attracting and retaining key officers, employees and directors of, and consultants to, the Company and its subsidiaries and affiliates, (ii) motivating those individuals by means of performance-related incentives to achieve long-range performance goals, (iii) enabling such individuals to participate in the long-term growth and financial success of the Company, (iv) encouraging ownership of stock in the Company by such individuals, and (v) linking their compensation to the long-term interests of the Company and its shareholders. Except for certain limitations, awards can be in the form of stock options (both incentive stock options and non-qualified stock options), stock appreciation rights, restricted shares and restricted share units, performance awards and other stock-based awards. As of December 31, 2019, the Company had 467,271 shares remaining available for issuance under the 2016 Equity Incentive Plan. As of  December 31, 2019, the Company had outstanding 120,843 stock options with a weighted average exercise price of $41.75 and 132,131 cash-settled stock appreciation rights each with a weighted average exercise price of $41.97.

 

As of December 31, 2019 the company had outstanding 140,908 stock options with a weighted average exercise price of $40.46 and 132,131 cash settled stock appreciation rights with a weighted average exercise price of $41.97.

 

The fair value of each stock option and cash-settled SAR grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions used for grants in 2019, 2018 and 2017:

 

   

2019

   

2018

   

2017

 

Expected dividends

    1.60 %     1.22 %     1.27 %

Expected term (in years)

    7.14       9.35       7.79  

Expected stock price volatility

    25 %     24 %     26 %

Risk-free rate

    1.90 %     2.83 %     2.23 %

 

The expected stock price volatility is based on historical volatility adjusted for consideration of other relevant factors. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The dividend yield and forfeiture rate assumptions are based on the Company’s history and expectation of dividend payouts and forfeitures.

 

A summary of the stock option and cash-settled SAR activity for 2019, 2018 and 2017 is as follows:

 

   

2019

   

2018

   

2017

 
           

Weighted Average

           

Weighted Average

           

Weighted Average

 
   

Shares

   

Exercise Price

   

Shares

   

Exercise Price

   

Shares

   

Exercise Price

 

Outstanding at beginning of year

    277,820     $ 40.11       285,780     $ 39.31       183,747     $ 38.09  

Granted

    17,833       51.16       21,666       46.59       112,333       40.87  

Exercised

    (22,614 )     35.78       (22,460 )     37.07       (5,078 )     29.65  

Forfeited or expired

    0       0       (7,166 )     37.53       (5,222 )     39.22  

Outstanding at end of year

    273,039     $ 41.19       277,820     $ 40.11       285,780     $ 39.31  

Options and cash-settled SARs exercisable at year end

    122,932     $ 40.19       94,951     $ 39.14       42,256     $ 36.66  

 

The weighted average fair value at the grant date of options and cash-settled SARs granted during the years 2019, 2018 and 2017 was $13.43, $14.41 and $12.59, respectively. The total intrinsic value of options and cash-settled SARs exercised during the years 2019, 2018 and 2017 was $369,000, $200,000 and $62,000, respectively.

 

The following table summarizes information about outstanding and exercisable stock options and cash-settled SARs at   December 31, 2019:

 

   

Options and Cash-Settled SARs Outstanding

   

Options and Cash-Settled SARs Exercisable

 
                   

Weighted Average

                   

Weighted Average

 

Range of

 

Number

           

Remaining

   

Number

           

Remaining

 

Exercise

 

Outstanding at

   

Weighted Average

   

Contractual Term (In

   

Exercisable at

   

Weighted Average

   

Contractual Term (In

 

Prices

 

12/31/19

   

Exercise Price

   

Years)

   

12/31/19

   

Exercise Price

   

Years)

 

$28.00 - $38.00

  20,065   $ 32.66       2.98       8,487     $ 32.35       2.78  

$38.01 - $51.25

  252,974   $ 41.86       6.68       114,445     $ 40.77       5.74  
      273,039                       122,932                  

Aggregate intrinsic value (in thousands)

  $ 3,703                     $ 1,790                  

 

 

As of December 31, 2019, there was $1,622,000 of total unrecognized cost related to non-vested share-based compensation arrangements granted under the Company’s equity incentive plans. The cost is expected to be recognized over a weighted-average period of 2.51 years.